240 related articles for article (PubMed ID: 19470763)
21. Novel role for EKLF in megakaryocyte lineage commitment.
Frontelo P; Manwani D; Galdass M; Karsunky H; Lohmann F; Gallagher PG; Bieker JJ
Blood; 2007 Dec; 110(12):3871-80. PubMed ID: 17715392
[TBL] [Abstract][Full Text] [Related]
22. Furin gene (fur) regulation in differentiating human megakaryoblastic Dami cells: involvement of the proximal GATA recognition motif in the P1 promoter and impact on the maturation of furin substrates.
Laprise MH; Grondin F; Cayer P; McDonald PP; Dubois CM
Blood; 2002 Nov; 100(10):3578-87. PubMed ID: 12411321
[TBL] [Abstract][Full Text] [Related]
23. Biological and biochemical characteristics of murine megakaryoblastic cell line L8057.
Ishida Y; Levin J; Baker G; Stenberg PE; Yamada Y; Sasaki H; Inoue T
Exp Hematol; 1993 Feb; 21(2):289-98. PubMed ID: 7678813
[TBL] [Abstract][Full Text] [Related]
24. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation.
Shelly C; Petruzzelli L; Herrera R
Cell Growth Differ; 2000 Sep; 11(9):501-6. PubMed ID: 11007455
[TBL] [Abstract][Full Text] [Related]
25. Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation.
Lennard Richard ML; Nowling TK; Brandon D; Watson DK; Zhang XK
Mol Immunol; 2015 Feb; 63(2):566-73. PubMed ID: 25108845
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators.
Tijssen MR; Cvejic A; Joshi A; Hannah RL; Ferreira R; Forrai A; Bellissimo DC; Oram SH; Smethurst PA; Wilson NK; Wang X; Ottersbach K; Stemple DL; Green AR; Ouwehand WH; Göttgens B
Dev Cell; 2011 May; 20(5):597-609. PubMed ID: 21571218
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenic Ets transcription factor Fli-1.
Bastian LS; Kwiatkowski BA; Breininger J; Danner S; Roth G
Blood; 1999 Apr; 93(8):2637-44. PubMed ID: 10194443
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of murine committed megakaryocytic progenitors isolated by a novel strategy reveals the complexity of GATA and Ets factor involvement in megakaryocytopoiesis and an unexpected potential role for GATA-6.
Dumon S; Heath VL; Tomlinson MG; Göttgens B; Frampton J
Exp Hematol; 2006 May; 34(5):654-63. PubMed ID: 16647571
[TBL] [Abstract][Full Text] [Related]
29. Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage.
Kruse EA; Loughran SJ; Baldwin TM; Josefsson EC; Ellis S; Watson DK; Nurden P; Metcalf D; Hilton DJ; Alexander WS; Kile BT
Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13814-9. PubMed ID: 19666492
[TBL] [Abstract][Full Text] [Related]
30. Cloning and analysis of the thrombopoietin-induced megakaryocyte-specific glycoprotein VI promoter and its regulation by GATA-1, Fli-1, and Sp1.
Holmes ML; Bartle N; Eisbacher M; Chong BH
J Biol Chem; 2002 Dec; 277(50):48333-41. PubMed ID: 12359731
[TBL] [Abstract][Full Text] [Related]
31. Identification of nuclear import and export signals within Fli-1: roles of the nuclear import signals in Fli-1-dependent activation of megakaryocyte-specific promoters.
Hu W; Philips AS; Kwok JC; Eisbacher M; Chong BH
Mol Cell Biol; 2005 Apr; 25(8):3087-108. PubMed ID: 15798196
[TBL] [Abstract][Full Text] [Related]
32. PSTPIP2 dysregulation contributes to aberrant terminal differentiation in GATA-1-deficient megakaryocytes by activating LYN.
Liu L; Wen Q; Gong R; Gilles L; Stankiewicz MJ; Li W; Guo M; Li L; Sun X; Li W; Crispino JD; Huang Z
Cell Death Dis; 2014 Jan; 5(1):e988. PubMed ID: 24407241
[TBL] [Abstract][Full Text] [Related]
33. Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome.
Kumar MS; Narla A; Nonami A; Mullally A; Dimitrova N; Ball B; McAuley JR; Poveromo L; Kutok JL; Galili N; Raza A; Attar E; Gilliland DG; Jacks T; Ebert BL
Blood; 2011 Oct; 118(17):4666-73. PubMed ID: 21873545
[TBL] [Abstract][Full Text] [Related]
34. Forced GATA-1 expression in the murine myeloid cell line M1: induction of c-Mpl expression and megakaryocytic/erythroid differentiation.
Yamaguchi Y; Zon LI; Ackerman SJ; Yamamoto M; Suda T
Blood; 1998 Jan; 91(2):450-7. PubMed ID: 9427697
[TBL] [Abstract][Full Text] [Related]
35. TEThered to Runx: novel binding partners for runx factors.
Li X; Decker M; Westendorf JJ
Blood Cells Mol Dis; 2010 Jun; 45(1):82-5. PubMed ID: 20362478
[TBL] [Abstract][Full Text] [Related]
36. RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.
Okada Y; Watanabe M; Nakai T; Kamikawa Y; Shimizu M; Fukuhara Y; Yonekura M; Matsuura E; Hoshika Y; Nagai R; Aird WC; Doi T
J Thromb Haemost; 2013 Sep; 11(9):1742-50. PubMed ID: 23848403
[TBL] [Abstract][Full Text] [Related]
37. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis.
Liu T; Yao Y; Zhang G; Wang Y; Deng B; Song J; Li X; Han F; Xiao X; Yang J; Xia L; Li YJ; Plachynta M; Zhang M; Yan C; Mu S; Luo H; Zacksenhaus E; Hao X; Ben-David Y
Oncotarget; 2017 Mar; 8(10):16728-16743. PubMed ID: 28052010
[TBL] [Abstract][Full Text] [Related]
38. Induction of megakaryocyte differentiation drives nuclear accumulation and transcriptional function of MKL1 via actin polymerization and RhoA activation.
Smith EC; Teixeira AM; Chen RC; Wang L; Gao Y; Hahn KL; Krause DS
Blood; 2013 Feb; 121(7):1094-101. PubMed ID: 23243284
[TBL] [Abstract][Full Text] [Related]
39. Functional cross-antagonism between transcription factors FLI-1 and EKLF.
Starck J; Cohet N; Gonnet C; Sarrazin S; Doubeikovskaia Z; Doubeikovski A; Verger A; Duterque-Coquillaud M; Morle F
Mol Cell Biol; 2003 Feb; 23(4):1390-402. PubMed ID: 12556498
[TBL] [Abstract][Full Text] [Related]
40. Expression of GM-CSF Is Regulated by Fli-1 Transcription Factor, a Potential Drug Target.
Wang X; Lennard Richard M; Li P; Henry B; Schutt S; Yu XZ; Fan H; Zhang W; Gilkeson G; Zhang XK
J Immunol; 2021 Jan; 206(1):59-66. PubMed ID: 33268481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
